Riskpilot← Back to searchSign inGet full accessCAFÉ BLÅGÅRDS APOTEK ApS
APSActiveCVR 31896738Blågårdsgade 20Beverage serving activities · NACE 5630Est. 200918 employees
Revenue 2024
DKK 2,3M
-3% vs 2023
EBITDA margin
6.3%
-69% vs 2023
Equity ratio
46.9%
Financial strength
Net profit 2024
DKK 113K
-72% vs 2023
| Revenue | DKK 2,3M | -3% |
| EBITDA | DKK 147K | -69% |
| Net profit | DKK 113K | -72% |
| Total assets | DKK 1,3M | -1% |
| Equity | DKK 604K | +23% |
| Employees | 18 | — |
Legal name
CAFÉ BLÅGÅRDS APOTEK ApS
CVR number
31896738
Legal form
Anpartsselskab
NACE code
5630 · Beverage serving activities
Founded
7. januar 2009
Share capital
DKK 125.000
Employees
18 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Company purpose
Selskabets formål er at drive virksomhed inden for cafe- og restaurationsbranchen, pt. Café Blågårds Apotek, beliggende Blågårds Plads 20, København N.
Address
Blågårdsgade 20
Phone
+4535372442
Email
bestyrer@kroteket.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.843 | 1.580 | 1.437 | 1.698 | 1.701 | 1.825 | 1.879 | 1.829 | 1.648 | 1.820 | 1.838 | 2.404 | 2.338 |
| Staff expenses | -1.488 | -1.622 | -1.645 | -1.743 | -1.732 | -1.782 | -1.714 | -1.778 | -1.634 | -1.691 | -1.972 | -1.862 | -2.127 |
| EBITDA | 356 | -43 | -209 | -45 | -32 | 43 | 164 | 51 | 15 | 47 | -216 | 473 | 147 |
| Depreciation & amort. | -154 | -121 | -147 | -141 | -111 | -98 | -29 | -2 | -0 | -0 | -8 | -13 | -36 |
| EBIT | 201 | -164 | -356 | -185 | -143 | -55 | 135 | 49 | 15 | 47 | -224 | 460 | 111 |
| Net financials | -11 | -4 | -5 | 22 | -12 | -13 | -12 | 0 | -3 | -9 | -3 | -48 | 4 |
| Profit before tax | 190 | -167 | -361 | -164 | -155 | -67 | 123 | 49 | 12 | 39 | -227 | 411 | 115 |
| Tax | 51 | -44 | -34 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 4 | 3 |
| Net profit | 139 | -124 | -327 | -164 | -155 | -67 | 123 | 49 | 12 | 39 | -227 | 407 | 113 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2.215 | 1.173 | 791 | 900 | 791 | 780 | 739 | 734 | 1.281 | 1.517 | 956 | 1.300 | 1.288 |
| Equity | 1.801 | 801 | 474 | 310 | 155 | 88 | 211 | 260 | 273 | 311 | 84 | 491 | 604 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 151 | 0 | 0 |
| Short-term debt | 337 | 338 | 317 | 590 | 636 | 692 | 527 | 474 | 1.009 | 1.206 | 720 | 805 | 679 |
| Total debt | 337 | 338 | 317 | 590 | 636 | 692 | 527 | 474 | 1.009 | 1.206 | 872 | 805 | 679 |
EBITDA margin
6.3%
This company
15.8%
Market median
-60% vs market
20122024
Equity ratio
46.9%
This company
38.2%
Market median
+23% vs market
20122024
Return on equity
18.6%
This company
18.4%
Market median
+1% vs market
20122024
Net profit margin
4.8%
This company
8.1%
Market median
-41% vs market
20122024
Asset turnover
1.82×
This company
1.12×
Market median
+62% vs market
20122024
Debt / equity
1.13×
This company
0.62×
Market median
-82% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JH Management | Management | 2014 | — | — |
CJ Management | Management | 2012 | — | — |
CL Management | Management | 2009 | — | — |
UB Management | Management | 2010 | — | — |
EH Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
LM Management | Management | 2015 | — | — |
BA Founder | Founder | 2009 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
CAFÉ BLÅGÅRDS APOTEK VED HANS NIELSEN'S FOND | Company | 100.0% | 100.0% | 2012 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CAFÉ BLÅGÅRDS APOTEK VED HANS NIELSEN'S FOND
CAFÉ BLÅGÅRDS APOTEK ApS Board members of CAFÉ BLÅGÅRDS APOTEK ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jens Henckel Lannik | Management | 0 companies |
| Carsten Johansen | Management | 0 companies |
| Charlotte Lyck Ankersen | Management | 0 companies |
| Ulrich Bang Sørensen | Management | 0 companies |
| Ebbe Hede | Chief Executive Officer | 0 companies |
| Lise Marie Garde Hansen | Management | 0 companies |
| Birgitte Arnfred Kristensen | Founder | 0 companies |